Bioinformaticians have been utilizing machine learning for years. However, the introduction of powerful and easily accessible generative AI tools is a new horizon. Learning how to use these tools to ...

In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

King’s College London is one of the top research universities in the UK, with a strong tradition of interdisciplinary biomedical research. This role sits within a leading research group focused on ...

We are living in an era where biology has become synonymous with big data due to the ever-increasing amount of data being generated by technologies such as next-generation sequencing. Bioinformatics ...